中国麻风皮肤病杂志 ›› 2022, Vol. 38 ›› Issue (11): 833-836.doi: 10.12144/zgmfskin202211833

• 综述 • 上一篇    下一篇

药物相关性大疱性类天疱疮研究进展

谢卓廷1,李安妮1,张佩莲2   

  1. 1云南中医药大学第一临床医学院,云南昆明，650021；2云南省中医医院/云南中医药大学第一附属医院,云南昆明，650021
  • 出版日期:2022-11-15 发布日期:2022-10-26

Update of drug-associated bullous pemphigoid

XIE Zhuoting1, LI Anni1, ZHANG Peilian2   

  1. 1 First Clinical Medical College of Yunnan University of Chinese Medicine, Kunming 650021, China; 2 Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming 650021, China
  • Online:2022-11-15 Published:2022-10-26

PDF (PC)

286

摘要： 药物相关性大疱性类天疱疮(drug-associated bullous pemphigoid，DABP)特指应用特定药物诱发的一种特殊类型的类天疱疮，其临床表现、组织学或免疫病理特征与特发性大疱性类天疱疮相同或相近。近年由药物导致大疱性类天疱疮的报道增多，本文就DABP的研究进展进行综述。

关键词: 大疱性类天疱疮, 药物相关性

Abstract: Drug-associated bullous pemphigoid(BP)is a special type of BP, and is commonly induced by drugs, which clinical, histological or immunopathological features are the same or similar to those of BP. In recent years, there are more and more reports of drug-associated bullous pemphigoid. The update of drug-associated bullous pemphigoid is reviewed in this paper.

Key words: bullous pemphigoid, drug-associated